Daiken Medical Co., Ltd. (TYO:7775)
470.00
+4.00 (0.86%)
Mar 10, 2026, 11:27 AM JST
Daiken Medical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 13,387 | 14,077 | 15,944 | 13,818 | 14,652 | 17,496 | Upgrade
|
| Market Cap Growth | -6.61% | -11.71% | 15.38% | -5.69% | -16.26% | -7.31% | Upgrade
|
| Enterprise Value | 12,855 | 13,444 | 15,955 | 14,329 | 15,410 | 18,475 | Upgrade
|
| Last Close Price | 466.00 | 480.54 | 520.30 | 434.32 | 441.70 | 508.91 | Upgrade
|
| PE Ratio | 13.65 | 12.83 | 16.14 | 19.41 | 17.63 | 25.92 | Upgrade
|
| PS Ratio | 1.32 | 1.42 | 1.64 | 1.51 | 1.72 | 2.23 | Upgrade
|
| PB Ratio | 1.74 | 1.87 | 2.27 | 2.10 | 2.27 | 2.83 | Upgrade
|
| P/TBV Ratio | 1.74 | 1.88 | 2.28 | 2.10 | 2.28 | 2.84 | Upgrade
|
| P/FCF Ratio | - | 14.76 | 11.45 | 17.47 | 15.74 | 58.32 | Upgrade
|
| P/OCF Ratio | - | 12.57 | 10.25 | 13.97 | 12.93 | 28.73 | Upgrade
|
| EV/Sales Ratio | 1.26 | 1.35 | 1.64 | 1.57 | 1.80 | 2.35 | Upgrade
|
| EV/EBITDA Ratio | - | 7.71 | 9.63 | 10.84 | 10.52 | 15.70 | Upgrade
|
| EV/EBIT Ratio | 9.80 | 8.89 | 11.06 | 13.58 | 13.39 | 20.06 | Upgrade
|
| EV/FCF Ratio | - | 14.09 | 11.45 | 18.12 | 16.55 | 61.58 | Upgrade
|
| Debt / Equity Ratio | 0.24 | 0.27 | 0.31 | 0.42 | 0.46 | 0.48 | Upgrade
|
| Debt / EBITDA Ratio | - | 1.18 | 1.29 | 2.08 | 2.00 | 2.51 | Upgrade
|
| Debt / FCF Ratio | - | 2.15 | 1.54 | 3.48 | 3.15 | 9.84 | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.13 | -0.08 | 0.04 | 0.06 | 0.13 | Upgrade
|
| Net Debt / EBITDA Ratio | - | -0.54 | -0.36 | 0.18 | 0.28 | 0.67 | Upgrade
|
| Net Debt / FCF Ratio | - | -0.99 | -0.43 | 0.30 | 0.45 | 2.61 | Upgrade
|
| Asset Turnover | 0.90 | 0.90 | 0.89 | 0.83 | 0.79 | 0.72 | Upgrade
|
| Inventory Turnover | 4.56 | 4.08 | 3.91 | 3.67 | 3.28 | 3.47 | Upgrade
|
| Quick Ratio | 1.82 | 1.93 | 1.56 | 1.50 | 1.57 | 1.42 | Upgrade
|
| Current Ratio | 2.40 | 2.47 | 2.02 | 1.97 | 2.09 | 1.87 | Upgrade
|
| Return on Equity (ROE) | 13.01% | 15.09% | 14.51% | 10.92% | 13.16% | 11.01% | Upgrade
|
| Return on Assets (ROA) | 7.29% | 8.52% | 8.19% | 6.01% | 6.64% | 5.29% | Upgrade
|
| Return on Invested Capital (ROIC) | 13.94% | 16.94% | 14.99% | 10.71% | 12.02% | 9.69% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.90% | 18.10% | 18.80% | 13.80% | 14.80% | 12.40% | Upgrade
|
| Earnings Yield | 7.33% | 7.79% | 6.20% | 5.15% | 5.67% | 3.86% | Upgrade
|
| FCF Yield | - | 6.78% | 8.74% | 5.72% | 6.35% | 1.71% | Upgrade
|
| Payout Ratio | - | 55.79% | 58.00% | 79.35% | 69.07% | 85.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.